Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Saved in:
| Title: | Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. |
|---|---|
| Authors: | Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Selig W; WSCollaborative, McLean, Virginia, USA., Meehan C; National Brain Tumor Society, Newton, Massachusetts, USA., Bacha J; Edison Oncology Holding Corp., Menlo Park, California, USA., Barone A; Office of Hematology and Oncology Products at the Food and Drug Administration, Silver Spring, Maryland, USA., Bloomquist E; Office of Biostatistics, Center for Drug Evaluation and Research at the Food and Drug Administration, Silver Spring, Maryland, USA., Chang SM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., de Groot JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Galanis E; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hassan I; Agios Pharmaceuticals, Cambridge, Massachusetts, USA., Kalidas C; Bayer Pharmaceuticals, Hillsborough, New Jersey, USA., Khasraw M; Preston Robert Tisch Brain Tumor Center at Duke, Departments of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., Kvedar JC; Department of Dermatology at Massachusetts General Hospital, Boston, Massachusetts, USA., Lassman AB; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA., Puduvalli V; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sahebjam S; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Schwamm LH; Department of Neurology at Massachusetts General Hospital, Boston, Massachusetts, USA., Tamir S; Karyopharm Therapeutics, Inc., Newton, Massachusetts, USA., Welch M; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA., Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zadeh G; MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada., Arons D; National Brain Tumor Society, Newton, Massachusetts, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2021 Aug 02; Vol. 23 (8), pp. 1252-1260. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33822177 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lee+EQ%22">Lee EQ</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Selig+W%22">Selig W</searchLink>; WSCollaborative, McLean, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Meehan+C%22">Meehan C</searchLink>; National Brain Tumor Society, Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bacha+J%22">Bacha J</searchLink>; Edison Oncology Holding Corp., Menlo Park, California, USA.<br /><searchLink fieldCode="AU" term="%22Barone+A%22">Barone A</searchLink>; Office of Hematology and Oncology Products at the Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bloomquist+E%22">Bloomquist E</searchLink>; Office of Biostatistics, Center for Drug Evaluation and Research at the Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chang+SM%22">Chang SM</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22de+Groot+JF%22">de Groot JF</searchLink>; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Galanis+E%22">Galanis E</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Hassan+I%22">Hassan I</searchLink>; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kalidas+C%22">Kalidas C</searchLink>; Bayer Pharmaceuticals, Hillsborough, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Khasraw+M%22">Khasraw M</searchLink>; Preston Robert Tisch Brain Tumor Center at Duke, Departments of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Kvedar+JC%22">Kvedar JC</searchLink>; Department of Dermatology at Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lassman+AB%22">Lassman AB</searchLink>; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Puduvalli+V%22">Puduvalli V</searchLink>; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Sahebjam+S%22">Sahebjam S</searchLink>; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Schwamm+LH%22">Schwamm LH</searchLink>; Department of Neurology at Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Tamir+S%22">Tamir S</searchLink>; Karyopharm Therapeutics, Inc., Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Welch+M%22">Welch M</searchLink>; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Yung+WKA%22">Yung WKA</searchLink>; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zadeh+G%22">Zadeh G</searchLink>; MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Arons+D%22">Arons D</searchLink>; National Brain Tumor Society, Newton, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wen+PY%22">Wen PY</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2021 Aug 02; Vol. 23 (8), pp. 1252-1260. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33822177 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/neuonc/noab082 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1252 Titles: – TitleFull: Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lee EQ – PersonEntity: Name: NameFull: Selig W – PersonEntity: Name: NameFull: Meehan C – PersonEntity: Name: NameFull: Bacha J – PersonEntity: Name: NameFull: Barone A – PersonEntity: Name: NameFull: Bloomquist E – PersonEntity: Name: NameFull: Chang SM – PersonEntity: Name: NameFull: de Groot JF – PersonEntity: Name: NameFull: Galanis E – PersonEntity: Name: NameFull: Hassan I – PersonEntity: Name: NameFull: Kalidas C – PersonEntity: Name: NameFull: Khasraw M – PersonEntity: Name: NameFull: Kvedar JC – PersonEntity: Name: NameFull: Lassman AB – PersonEntity: Name: NameFull: Puduvalli V – PersonEntity: Name: NameFull: Sahebjam S – PersonEntity: Name: NameFull: Schwamm LH – PersonEntity: Name: NameFull: Tamir S – PersonEntity: Name: NameFull: Welch M – PersonEntity: Name: NameFull: Yung WKA – PersonEntity: Name: NameFull: Zadeh G – PersonEntity: Name: NameFull: Arons D – PersonEntity: Name: NameFull: Wen PY IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 08 Text: 2021 Aug 02 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1523-5866 Numbering: – Type: volume Value: 23 – Type: issue Value: 8 Titles: – TitleFull: Neuro-oncology Type: main |
| ResultId | 1 |